Azesto Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.00 Cr
- Revenue Growth 12.50%
- Profit Growth 17.49%
- Ebitda 539.06%
- Net Worth 83.55%
- Total Assets 65.05%
About Azesto Impex
Azesto Impex Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 April 2015 (Nine years and ten months 9 days old ). Its registered office is in Nagpur, Maharashtra.
The Corporate was formerly known as B S Medicine & Foods Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Barun Chauhan and Sachin Makade serve as directors at the Company.
Company Details
- Location Nagpur, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52100MH2015PTC263333
-
Company No.
263333
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Apr 2015
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Azesto Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Barun Chauhan
|
Director | 07-Apr-2015 | Current |
|
Sachin Makade
|
Director | 07-Apr-2015 | Current |
Financial Performance of Azesto Impex.
Azesto Impex Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.5% increase. The company also saw a substantial improvement in profitability, with a 17.49% increase in profit. The company's net worth Soared by an impressive increase of 83.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azesto Impex?
In 2019, Azesto Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2019 | Hdfc Bank Limited | ₹5.00 M | Open |
| 09 Apr 2019 | Hdfc Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Azesto Impex?
Unlock and access historical data on people associated with Azesto Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azesto Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azesto Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.